NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Gardiner Healthcare
Acquisitions Corp. (NASDAQ: GDNRU, the "Company") announced today
that an additional 1,125,000 units were issued pursuant to the
underwriters' exercise in full of its over-allotment option in
connection with the Company's initial public offering. The offering
was priced at $10.00 per unit,
generating additional gross proceeds of $11,250,000 and bringing the total gross proceeds
of the initial public offering to $86,250,000.
The Company's units commenced trading on the Nasdaq Global
Market ("NASDAQ") under the ticker symbol "GDNRU" on December 22, 2021. Each unit consists of one
share of common stock and one warrant, with each warrant entitling
the holder thereof to purchase one share of common stock at a price
of $11.50 per share. Once the securities comprising the
units begin separate trading, the common stock and warrants are
expected to be listed on NASDAQ under the symbols "GDNR" and
"GDNRW" respectively.
Chardan acted as the sole book-running manager in the offering.
B. Riley Securities, Inc. acted as qualified independent
underwriter in the offering.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
December 21, 2021. The offering was
made only by means of a prospectus, copies of which may be obtained
by contacting Chardan, 17 State Street, 21st floor, New York, New York 10004. Copies of the
registration statement can be accessed through the SEC's website at
www.sec.gov.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Gardiner Healthcare Acquisitions Corp.
Gardiner Healthcare Acquisitions Corp. is a Delaware corporation incorporated as a blank
check company for the purpose of entering into a merger, share
exchange, asset acquisition, share purchase, recapitalization,
reorganization or similar business combination with one or more
businesses or entities. While we may pursue an acquisition
opportunity in any business, industry, sector or geographical
location, we intend to focus on industries that complement our
management team's background, and to capitalize on the ability of
our management team to identify and acquire a business, focusing on
the healthcare or healthcare related industries. In particular, we
may target North American or European companies in the life
sciences and medical technology sectors, with a specific focus on
small and large molecule therapeutics.
Forward Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward looking statements are
statements that are not historical facts. Such forward-looking
statements are subject to risks and uncertainties, which could
cause actual results to differ from the forward looking statements.
The Company expressly disclaims any obligations or undertaking to
release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in the Company's
expectations with respect thereto or any change in events,
conditions or circumstances on which any statement is based.
Marc F. Pelletier, PhD
Gardiner Healthcare Acquisitions Corp.
IR@gardinerhealthcare.com
View original
content:https://www.prnewswire.com/news-releases/gardiner-healthcare-acquisitions-corp-announces-closing-of-over-allotment-option-in-connection-with-its-initial-public-offering-301451609.html
SOURCE Gardiner Healthcare Acquisitions Corp.